Panbela Therapeutics, Inc. (PBLA) Tops Q3 EPS by 2c

Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q3 EPS of ($0.21), $0.02 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• KeyBanc Reiterates Overweight Rating on Brinker Int'l (EAT)
• Raymond James Reiterates Underperform Rating on Lennar (LEN)